The Polycomb group of epigenetic enzymes represses expression of developmentally regulated genes in many eukaryotes. This group includes the Polycomb repressive complex 1 (PRC1), which ubiquitylates nucleosomal histone H2A Lys 119 using its E3 ubiquitin ligase subunits, Ring1B and Bmi1, together with an E2 ubiquitin-conjugating enzyme, UbcH5c. However, the molecular mechanism of nucleosome substrate recognition by PRC1 or other chromatin enzymes is unclear. Here we present the crystal structure of the human Ring1B-Bmi1-UbcH5c E3-E2 complex (the PRC1 ubiquitylation module) bound to its nucleosome core particle substrate. The structure shows how a chromatin enzyme achieves substrate specificity by interacting with several nucleosome surfaces spatially distinct from the site of catalysis. Our structure further reveals an unexpected role for the ubiquitin E2 enzyme in substrate recognition, and provides insight into how the related histone H2A E3 ligase, BRCA1, interacts with and ubiquitylates the nucleosome.
The Polycomb group of epigenetic enzymes represses expression of developmentally regulated genes in many eukaryotes. This group includes the Polycomb repressive complex 1 (PRC1), which ubiquitylates nucleosomal histone H2A Lys 119 using its E3 ubiquitin ligase subunits, Ring1B and Bmi1, together with an E2 ubiquitin-conjugating enzyme, UbcH5c. However, the molecular mechanism of nucleosome substrate recognition by PRC1 or other chromatin enzymes is unclear. Here we present the crystal structure of the human Ring1B-Bmi1-UbcH5c E3-E2 complex (the PRC1 ubiquitylation module) bound to its nucleosome core particle substrate. The structure shows how a chromatin enzyme achieves substrate specificity by interacting with several nucleosome surfaces spatially distinct from the site of catalysis. Our structure further reveals an unexpected role for the ubiquitin E2 enzyme in substrate recognition, and provides insight into how the related histone H2A E3 ligase, BRCA1, interacts with and ubiquitylates the nucleosome.
The Polycomb group (PcG) proteins are transcriptional repressors that correlate with diverse human cancers and constitute key epigenetic regulators of stem-cell self-renewal and lineage development [1] [2] [3] [4] [5] . The PcG proteins assemble into multi-component complexes that remodel chromatin structure both directly and through the establishment and removal of histone post-translational modifications 6, 7 . One of these complexes, PRC1, monoubiquitylates histone H2A Lys 119 (refs 8, 9) . Once thought of as a unique complex, it is now clear that human PRC1 exists as a modular subset of complexes with distinct functions and gene targets 10, 11 . All PRC1 complexes share a common core -the RING-type E3 ubiquitin ligase composed of Ring1B (also known as RNF2) or Ring1A, and Bmi1 (also known as PCGF4) or one of five other Polycomb group RING finger (PCGF) paralogues with potential for H2A ubiquitylation. This E3 core combines with accessory subunits to form canonical and variant PRC1s. Variant complexes, especially those containing histone demethylase KDM2B and/or RYBP, seem to be primarily responsible for H2A ubiquitylation 10, [12] [13] [14] .
Protein ubiquitylation is accomplished through a cascade of E1, E2 and E3 enzymes 15 . First, an E1 activates and transfers ubiquitin to an E2-conjugating enzyme, forming a thioester between ubiquitin and a cysteine in the E2 active site. Then, in an E3-dependent manner, the carboxy terminus of ubiquitin is attached to the e-NH 2 of a target protein lysine side chain through an isopeptide bond. RING family E3 ligases, such as those found in PRC1, bridge an E2 and a target protein, presenting the target lysine to the E2 active site and constraining the geometry of the ubiquityl-E2 thioester, priming it for catalysis [16] [17] [18] . The E3 is considered the primary specificity determinant of ubiquitylation, reflecting the scarcity of E2s (,40 proteins in human) relative to E3s (more than 600 proteins) 19 .
Although the cognate E2 for PRC1 in vivo is not established, the Ring1B-Bmi1 E3 ligase can pair with one of several E2s, including UbcH5c (also known as UBE2D3), to ubiquitylate nucleosomes in vitro 20 . The nucleosome core particle (NCP) is the fundamental unit of the eukaryotic genome formed by 145-147 base pairs (bp) of DNA wrapped around an octameric scaffold of histone proteins (two copies each of H2A, H2B, H3 and H4) 21 . H2A-H2B dimers and H2A alone are not substrates for Ring1B-Bmi1, suggesting that surfaces formed only in the context of the nucleosome are required for the E3 ligase activity of PRC1 (refs 22, 23) . A minimal RING heterodimer of Ring1B and Bmi1 exhibits comparable activity to the full-length complex, implicating the RING domains in both E2 and substrate binding 20 . However, we lack a fundamental mechanistic understanding of how the Ring1B-Bmi1 E3 ligase interacts with the nucleosome to direct H2A Lys 119 ubiquitylation, or more generally, for how chromatin enzymes recognize their nucleosome substrate.
We have crystallized the PRC1 ubiquitylation module, an E2-E3 enzyme complex composed of UbcH5c and the minimal Ring1B-Bmi1 RING heterodimer, bound to its NCP substrate, and solved the structure at 3.3 Å resolution ( Supplementary Table 1 ). To our knowledge, this is the first crystal structure of a histone-modifying-enzyme-nucleosome complex or of a ubiquitin E2-E3-substrate complex. The structure shows that in contrast to most chromatin modification enzymes studied so far, the vast majority of interactions between the PRC1 ubiquitylation module and the nucleosome occur away from the catalytic site. Ring1B and Bmi1 bind to the histone surface of the NCP to orient UbcH5c for H2A ubiquitylation. Surprisingly, UbcH5c also makes direct contacts with the NCP that are crucial for nucleosome binding and ubiquitylation. This presents a novel role of ubiquitin E2 enzymes in substrate recognition.
Overview of complex
The structure shows one PRC1 ubiquitylation module bound to each disk face of the nucleosome (Fig. 1a, b ). The two PRC1 modules more than double the height of the NCP and with the exception of the C-terminal region of UbcH5c, are entirely contained within a cylinder projecting up from the NCP disk surface. Each PRC1 ubiquitylation module forms a crescent with two halves of the crescent contributed by the E2 and E3, respectively. The Ring1B-Bmi1 E3 heterodimer binds to the central histone surface of the NCP. The E2 UbcH5c completes the crescent, following the inner curvature of the DNA from its interface with Ring1B past the DNA end, ultimately terminating above the nucleosomal dyad. In this manner, the Ring1B-Bmi1 E3 ligase positions the active site of UbcH5c over the C-terminal tail of H2A near the target residue Lys 119 ( Fig. 1c ). All three components of the PRC1 ubiquitylation module contact histone and/or DNA components of the nucleosome burying 1,470 Å 2 of solvent accessible surface.
We selected UbcH5c for our structural studies owing to its high activity and thorough biochemical and structural characterization with Ring1B-Bmi1. To overcome the low affinity and salt-sensitive E2-E3 interaction 22 , we genetically fused the C terminus of the Ring1B fragment to the amino terminus of UbcH5c, converting the three-polypeptide PRC1 ubiquitylation module into a stable two-polypeptide version. The two fused PRC1 ubiquitylation modules in our structure align well with the previously determined Ring1B-Bmi1-UbcH5c structure 22 (root mean squared deviation (r.m.s.d.) of 1.0 Å over all backbone atoms), suggesting only minor structural changes after NCP binding and confirming the genetic fusion did not markedly alter the structure of the ubiquitylation module (Extended Data Fig. 1a -c, e). Such validation is especially important given that the fused PRC1 ubiquitylation module is inactive in a ubiquitylation assay owing to its inability to undergo E1-mediated transthiolation, presumably because the fused E3 clashes with ubiquitin in the E1 adenylation site 24 (Extended Data Fig. 2a, b ). The NCP is similarly largely unchanged compared to a published NCP structure using the same Widom 601 positioning sequence 25 (r.m.s.d. of 0.7 Å over all protein backbone atoms) (Extended Data Fig. 1d, e ).
Although the two PRC1 ubiquitylation modules bind their respective nucleosome faces in a similar manner, there are differences particularly at the UbcH5c-nucleosome interfaces. Alignment of the two sides of the structure through the pseudo-two-fold symmetry of the nucleosome reveals near uniformity between the histones on the two sides of the structure (r.m.s.d. of 0.7 Å ) (Extended Data Fig. 1f -i). By contrast, the PRC1 ubiquitylation modules from the two faces show more variation (r.m.s.d. of 1.9 Å and 4.6 Å for the E3 and E2 components, respectively), resulting from a flexing of a hinge at the Ring1B-Bmi1-nucleosome interface. Regions of the PRC1 ubiquitylation module close to this hinge, including the Ring1B-Bmi1 nucleosome-binding loops, are very similar on the opposing surfaces of the structure, whereas regions further from the hinge, notably the UbcH5c-nucleosome interfaces, exhibit larger differences. As a result, UbcH5c approaches the NCP more closely on one side (proximal side) of the structure than the other (distal side).
Although we cannot rule out the possibility of plasticity in the UbcH5c-NCP interface, we suspect that the variation in the two halves of the structure result from different environments of each PRC1 module within the crystal lattice. This is not merely a result of the post-crystallization dehydration used to obtain 3.3 Å resolution diffraction, as molecular replacement solutions from data collected on less dehydrated crystals with larger unit cells also exhibit similar differences (data not shown). Because the distal side places UbcH5c too far from the nucleosome surface to be consistent with our biochemical studies, we favour the proximal side, which is depicted in the following figures. (Details provided below; the distal side and alignments can be found in Extended Data Fig. 3 .) Importantly, the differences between the two sides of the structure influence the extent rather than the presence of interactions at each of the PRC1-NCP interfaces (Extended Data Fig. 1j ).
Ring1B-Bmi1-histone interactions
Several basic surfaces of Ring1B and Bmi1 have been shown to be required for nucleosomal ubiquitylation and binding to short duplex DNA 22 . This informed a structural model docking the Ring1B-Bmi1 heterodimer on DNA near the nucleosome dyad, positioning UbcH5c in proximity to H2A Lys 119 (ref. 22) . However, recent work implicating the H2A-H2B acidic patch in Ring1B-Bmi1-mediated H2A ubiquitylation in vitro and in vivo 26 is inconsistent with this docking model. Our structure reveals that the Ring1B-Bmi1 basic residues anticipated to bind DNA actually interact with histones surfaces, including the H2A-H2B acidic patch. The Ring1B-Bmi1 RING heterodimer, which contacts all four histones, forms a saddle over the N-terminal end of the H2B aC helix anchored on each side by Ring1B-and Bmi1-histone interactions (Extended Data Fig. 3a -c). Ring1B binds to the acidic patch of the H2A-H2B dimer. This interaction, which buries nearly 700 Å 2 of solventaccessible surface on the proximal side, is mediated by an intricate network of hydrogen bonds and van der Waals contacts and with few exceptions is limited to protein side chains ( Fig. 2a and Extended Data Fig. 3d -g, t, u). Consistent with published mutagenesis experiments 22, 26 , H2A Glu 92, Ring1B Lys 97 and Arg 98, and to a lesser extent Ring1B Lys 93 contribute to the Ring1B-nucleosome interface. Ring1B Arg 98 inserts into an acidic pocket generated by H2A residues Glu 61, Asp 90 and Glu 92, making charged hydrogen bonds with each of the H2A side-chain carboxylates. The depth of this pocket is augmented by a ridge composed of H2B residues Glu 105 and His 109, which make van der Waals contacts with the aliphatic region of the Arg 98 side chain. This model of nucleosomal recognition mediated by an 'arginine-anchor' binding to the H2A-H2B acidic patch is present in all chromatin factor-NCP crystal structures published so far [27] [28] [29] [30] (Extended Data Fig. 4 ). Ring1B Lys 97 
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projects into the acidic patch adjacent to Arg 98, hydrogen bonding to H2A residues Glu 61 and Glu 64. Not predicted by previous studies, Ring1B Arg 81 also binds to the acidic patch forming both side-chain and main-chain hydrogen bonds with H2A residues Asp 72 and Asn 89, respectively. This second arginine-binding site is distinct from sites observed in previous chromatin factor-NCP structures. Further contacts are mediated by Ring1B residues Lys 65, Lys 85, Lys 93 and Val95. With minor exceptions the Ring1B-NCP interface is identical on the proximal and distal faces. (Extended Data Fig. 3f , g) The considerable contribution of charged side chains to the Ring1B-nucleosome interface is consistent with the loss of nucleosomal ubiquitylation by the PRC1 ubiquitylation module at higher ionic strength 22 . The structural details of the Ring1B-acidic patch interface are validated by our mutagenesis experiments in solution. Tandem alanine mutations of H2A Glu 61 and Glu 64 or Asp 90 and Glu 92 (or the combination thereof) eliminate all detectable nucleosomal ubiquitylation ( Fig. 2c and Extended Data Fig. 5a ). Nucleosomes containing the H2A Asn68Ala/ Asp72Ala double mutant at the secondary arginine-binding site exhibit roughly half wild-type activity levels. To assess the effects of mutations in the PRC1 ubiquitylation module quantitatively, we established fluorescence-based nucleosome ubiquitylation and binding assays 31 (Extended Data Fig. 6 ). The Ring1B Arg98Ala mutation results in a 50-fold decrease in both nucleosomal ubiquitylation and the affinity of the fused PRC1 ubiquitylation module for the nucleosome (Fig. 2d, e ). Alanine mutations of Ring1B Lys 97, Arg 81 and Lys 93 have similar, yet decreasing effects on nucleosome ubiquitylation and binding, whereas the Ring1B Lys59Ala mutation away from the binding site has little to no effect on PRC1 function.
In contrast to the large Ring1B-NCP interface, the Bmi1-NCP interface is less extensive, burying only 330 Å 2 . Bmi1 forms a cap on the C-terminal end of the a1 helix of H3 with a Polycomb-specific RING domain loop insertion ( Fig. 2b and Extended Data Fig. 3h -k, v, w). This region was previously implicated in PRC1 function given the reduced activity of a Bmi1(Lys62Ala/Arg64Ala) mutant 22 . These residues form charged hydrogen bonds with H4 Glu 74 and H3 Asp 77, respectively. The intervening Thr 63 side chain inserts into a small cavity created by the end of the a1 helix and the neighbouring L1 loop of H3, contributing substantial van der Waals contact surface and forming a hydrogen bond with the H3 Gln 76 main-chain carbonyl oxygen. An additional hydrogen bond is made between Bmi1 Glu 33 and H2B Lys 108. The distal side Bmi1-NCP interface shares architectural similarity to its proximal counterpart with the exception of insufficient density to model the Lys 62 side chain (Extended Data Fig. 3j, k) .
Mutagenesis of the Bmi1-NCP interface allows us to assess the importance of this surface relative to the Ring1B-NCP interface. The consequences of the Bmi1(Arg64Ala) mutation are comparable to that of Ring1B(Lys93Ala), the least deleterious mutant tested at the Ring1B-NCP interface (Extended Data Fig. 7d-f and Supplementary Table 2 ). Meanwhile alanine mutations of His 61 and Lys 62 at the Bmi1-NCP interface and Arg 45 removed from the interface exhibit near wild-type behaviour. A charge reversal mutation of the underlying histone surface (H3(Asp77Arg)-H4(Glu74Arg)) decreases ubiquitylation by ,80% (Extended Data Fig. 5a ). This reduction in activity is smaller than that resulting from alanine mutations at the Ring1B-NCP interface. Paradoxically, a Bmi1(Glu33Ala) mutation both markedly decreases nucleosomal ubiquitylation and slightly increases nucleosomal binding affinity. We do not fully understand this phenomenon but it may relate to perturbation of the E3 heterodimer given the location of this side chain at the Ring1B-Bmi1 interface. Overall, our studies suggest a dominant role for Ring1B in the nucleosome binding of PRC1. The 25-fold enhancement 
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of Ring1B activity by Bmi1 (refs 9, 20) probably represents the modest role for Bmi1 in NCP binding together with a role in constraining ubiquitin at the Bmi1-ubiquitin interface [16] [17] [18] .
In human PRC1 complexes, Bmi1 can be replaced by five paralogues also known as PCGF proteins 11 . The sequence conservation of these paralogues combined with our structural and biochemical data suggest that each PCGF protein RING domain could support H2A ubiquitylation (Extended Data Fig. 8a ). Bmi1 Glu 33 is absolutely conserved mirroring its importance for nucleosomal ubiquitylation. Moreover, Thr 63 and Arg 64 show sequence similarity, maintaining both overall sidechain size and hydrophilicity. Meanwhile, Lys 62, which is dispensable for nucleosomal ubiquitylation, exhibits far less conservation and is replaced by negatively charged side chains in two of the paralogues. The lack of H2A ubiquitylation by canonical PRC1 complexes may reflect masking of the E3 interfaces with either the nucleosome or its E2. Alternatively, the nucleosome surface surrounding H2A Lys 119 may become inaccessible, secondary to canonical PRC1-mediated chromatin compaction. Further structural characterization of canonical and variant PRC1 alone and in complex with oligonucleosomes may shed light on this phenomenon.
UbcH5c-nucleosomal DNA interactions
Nucleosomal binding by the Ring1B-Bmi1 E3 ligase minimal RING heterodimer positions the E2 UbcH5c with its active site directly over the H2A C-terminal tail near the target Lys 119 (Fig. 1c ). However, UbcH5c scarcely contacts the underlying nucleosomal histone surface. The lack of E2 active-site-substrate specific interactions may allow UbcH5c to efficiently ubiquitylate several substrates by pairing with different E3 ligases, although we cannot rule out nucleosome-specific contacts by other potential E2s. This contrasts the direct recognition of the target lysine and surrounding consensus sequence by the related E2 Ubc9 in the SUMO-RanGAP1-Ubc9-Nup358 E2-E3 product crystal structure 32 . On the other hand, UbcH5c does interact with the nucleosome using two non-active site surfaces to bind nucleosomal DNA near the DNA end between superhelical location (SHL) 6 and 7 and at the nucleosomal dyad (Fig. 3a, b and Extended Data Fig. 3l-s) . These interfaces vary considerably on the proximal and distal sides of the crystal structure. At the DNA end interface, the UbcH5c antiparallel sheet aligns the side chains of His 32, His 55 and Lys 66, directing them towards the DNA backbone ( Fig. 3a ). This allows Lys 66 and His 32 to form hydrogen bonds with adjacent DNA phosphate groups on the proximal side of the structure. His 55 and Thr 58 side chains also approach the neighbouring phosphodiester backbone (3.6 and 3.9 Å , respectively). On the distal side of the crystal structure, each of these residues is ,2 Å farther from the nucleosome surface, limiting direct contact to the Lys 66 side chain that lies 4.1 Å from the DNA backbone (Extended Data Fig. 3n, o) . In addition to these backbone interactions, Asn 81 projects into the major groove at the DNA end, although it is unclear in our structure whether base specific recognition occurs.
UbcH5c also contacts the nucleosomal DNA again as its a3 helix tracks across the nucleosomal dyad (Fig. 3b ). On the proximal side, the UbcH5c Arg 125 side chain forms a hydrogen bond with the phosphate in position 1. Although the weaker density in this region of the structure prevents modelling of the Lys 128 side chain, the Lys 128 Cb is only 3.9 Å from the phosphate backbone at the dyad, allowing for further contacts. A ,3 Å translation of the distal side UbcH5 a3 helix along its axis results in a minor rearrangement of the distal interface (Extended Data Fig. 3r, s) . Notably, a hydrogen bond is observed between the Lys 128 side chain and the dyad phosphate on the distal side.
Given the novelty of this E2-substrate interaction, we further examined the role of UbcH5c in nucleosomal binding by the PRC1 ubiquitylation module in solution. We initially noted that the fused PRC1 complex binds to the NCP with nearly tenfold increased affinity as compared to Ring1B-Bmi1 alone ( Fig. 3c and Supplementary Table 2 ). Titration of UbcH5c in trans incrementally increases the affinity of the Ring1B-Bmi1-NCP interaction, verifying contributions by UbcH5c to nucleosomal binding. At 25 mM UbcH5c (,2.53 the E2-E3 dissociation constant (K d ) under assay conditions 22 ), the near-saturated, unfused PRC1 ubiquitylation module mimics its fused counterpart both in nucleosome affinity and raw fluorescence change, further validating the use of the fused complex in the structure and to interrogate effects of mutagenesis of all three PRC1 ubiquitylation module components ( Fig. 3c and data not shown). Importantly, the Ring1B Asp56Lys mutation that prevents Ring1B-UbcH5c binding 22 eliminates affinity changes mediated by UbcH5c in trans (Supplementary Table 2 ).
Having established a role for UbcH5c in nucleosome binding, we next addressed the contributions from the DNA end and DNA dyad interfaces. The UbcH5c(Lys66Glu) charge reversal mutation decreased nucleosomal affinity and ubiquitylation approximately tenfold (Extended Data Fig. 7g 
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with the UbcH5c(Arg125Glu/Lys128Glu) double mutation, although the nucleosomal affinity of this mutant complex could not be calculated owing to aggregation of the complex at high concentrations under assay conditions. The UbcH5c(Thr58Glu) mutant also exhibited significant although less severe defects in binding and ubiquitylation, whereas the Arg136Glu/Arg139Glu negative control mutant away from the NCP surface exhibited wild-type activity. Altogether, these results implicate both DNA end and DNA dyad interfaces in PRC1 function. The fused PRC1 ubiquitylation module with the UbcH5c(Lys66Glu) charge reversal mutant bound less tightly to the nucleosome than the Ring1B-Bmi1 subcomplex alone, suggesting a repulsive effect in addition to loss of any native interactions. Analysis of alanine mutations provides evidence for the role of UbcH5c side chains in nucleosome binding. At the DNA end interface, the UbcH5c(Lys66Ala) mutation caused a 50% reduction in nucleosome ubiquitylation and a sixfold decrease in nucleosome affinity (Extended Data Fig. 7j -l and Supplementary Table 2 ). The neighbouring Arg72Ala and His32Ala/His55Ala mutations also showed measurable but more muted effects relative to wild-type proteins. At the dyad interface, the Arg125Ala/Lys128Ala double mutant mimicked the Lys66Ala mutant with a 60% and sixfold reduction in nucleosome ubiquitylation and binding, respectively. Individual alanine mutations of Arg 125 and Lys 128 caused nearly identical intermediate effects. Unlike the charge reversal mutations, all fused complexes bearing UbcH5c alanine mutations bound to the nucleosome with affinities weaker than that of the fused wild-type complex but stronger than the Ring1B-Bmi1 subcomplex alone, implicating the side chains in nucleosome binding. All UbcH5c mutants have similar intrinsic activity as measured by lysine aminolysis of ubiquitin-charged E2s 33 (Extended Data Fig. 2c ).
Because the variation between the proximal and distal sides of the structure is greatest at the UbcH5c-DNA end interface, our functional studies present an opportunity to assess the relative authenticity of the two sides. For example, the UbcH5c His 32 and His 55 side chains are 3.3 and 3.6 Å from the DNA backbone on the proximal side, and 5.1 and 7.1 Å on the distal side, respectively. Mutation of both histidines to alanine decreases nucleosomal affinity 1.5-fold while causing a 30% reduction in enzymatic activity. Because the histidine-DNA backbone distances on the proximal side of the structure are more consistent with our biochemical studies, we favour this side as the better representation of the solution state interaction.
Further inspection of the structure suggests potential for additional interactions between UbcH5c and nucleosomal linker DNA (Extended Data Fig. 9a, b) . The UbcH5c C-terminal a4 helix rests across the major groove of linear B-form DNA modelled onto the end of the NCP. The DNA-adjacent helical face includes two positively charged and two aromatic side chains. Consistent with this hypothesis, we find that the PRC1 ubiquitylation module binds to nucleosomes centred on 185 bp 601 DNA with twice the affinity of those reconstituted with 147 bp 601 DNA (Extended Data Fig. 9c ). The absence of linker DNA required for these interactions in our crystals may explain the apparent flexibility of the a4 helices suggested by weaker electron density and higher B-factors.
In addition to UbcH5c, the Ring1B-Bmi1 E3 ligase can also pair with UbcH5a (also known as UBE2D1), UbcH5b (UBE2D2) and UbcH6 (UBE2E1) 20 . Meanwhile five other E2s cannot substitute for UbcH5c. These functional classes could result from compatibility differences at the E2-NCP and/or E2-E3 interfaces. Sequence alignment of E2s suggests the possibility that multiple positions including Arg 125 combine to determine PRC1 complementarity (Extended Data Fig. 8b) .
Nucleosome recognition by BRCA1
Despite contributions from Bmi1 and UbcH5c, Ring1B is the major contributor to nucleosome recognition as evidenced by buried surface area calculations and the magnitude of effects of Ring1B mutations on nucleosome binding and ubiquitylation. We wondered whether another E3 ligase, BRCA1, recently shown to target nucleosomal H2A Lys 127 and Lys 129 (ref. 34) specifically, might use a similar nucleosome recognition pattern. Much like Ring1B, BRCA1 uses its N-terminal RING domain to pair with the BARD1 RING domain to form a heterodimeric RING-type E3 ligase 35 . Structural and sequence alignment shows a high level of conservation between the nucleosome-binding loop of Ring1B and the corresponding BRCA1 region, including the Lys-Arg motif (Extended Data Fig. 10a, b ). We find that disruption of this motif with the Lys70Ala/Arg71Ala double mutation eliminates nucleosomal ubiquitylation by the BRCA1-BARD1 RING heterodimer (Extended Data Fig. 10c, d) . A similar loss of activity was observed after mutation of the H2A-H2B acidic patch (Extended Data Fig. 5b ). This suggests the possibility that like Ring1B, BRCA1 uses basic residues in the putative nucleosome-binding loop to bind to the nucleosomal H2A-H2B acidic patch. However, as Ring1B and BRCA1 target different H2A residues (Lys 119 versus Lys 127/Lys 129), additional BRCA1-BARD1 contacts may alter its orientation on the nucleosome.
Nucleosomal H2A specificity
The PRC1 ubiquitylation module requires a nucleosome substrate, showing no activity on an H2A-H2B dimer. Our structure indicates that Ring1B, Bmi1 and UbcH5c interact with nucleosomal H2A-H2B, H3-H4 and DNA, respectively, providing a mechanistic basis for nucleosome specificity. We also believe that the nucleosome has an additional 
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role in presenting the H2A C-terminal tail to the UbcH5c active site. In the context of the H2A-H2B dimer, the H2A C-terminal tail is expected to be unstructured beyond residue 105 assigning an entropic cost to ubiquitylation of Lys 119 (ref. 36 ). However, within the nucleosome, H2A adopts an elongated structure between residues 105 and 117, resting on a platform generated by the underlying H3 surface 21 . Residues beyond this structured region are more flexible, as suggested by the inability to model beyond Lys 118 in many NCP crystal structures 25, [28] [29] [30] . As such, the nucleosome both constrains the H2A C-terminal tail trajectory while allowing localized flexibility to reach the UbcH5c active site.
Despite the large number of lysine residues in the nucleosome, the PRC1 ubiquitylation module is specific for H2A Lys 119 and to a lesser extent Lys 118. In our structure, electron density is weak after Pro 117 allowing only main-chain atoms to be built to Lys 119 and Lys 118 on the proximal and distal sides, respectively. Neither main-chain trajectory indicates binding to the UbcH5c active site cleft. To verify that the UbcH5c positions within our structure are compatible with catalysis, we modelled the tetrahedral ubiquitylation transition state using H2A Lys 118 and 119 on each side of the structure (model for proximal side Lys 119 shown in Fig. 4) . Aside from the tetrahedral centre, ubiquitin makes no contact with the nucleosome surface in these models. This echoes the lack of SUMO-RanGAP1 interactions in the SUMO-RanGAP1-Ubc9-Nup358 E2-E3 product structure 32 . We find the position of UbcH5c on both sides of the structure is consistent with H2A Lys 118 and Lys 119 ubiquitylation. Moreover, our structure suggests nucleosome ubiquitylation is limited to these two lysines because UbcH5c is constrained in close proximity to the nucleosome surface, which prevents other lysines from entering the active site. Overall, the multifaceted interaction of the PRC1 ubiquitylation module with the nucleosome and the nucleosomal organization of the H2A C-terminal tail seem to combine to effect H2A ubiquitylation. More generally, our structure illustrates how a chromatin enzyme can use several non-active site surfaces for nucleosome recognition and specificity determination. We anticipate this principle to be shared by many chromatin enzymes that, like PRC1, function as part of large multi-component complexes.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
METHODS
Preparation of proteins, protein complexes and NCPs. Complete genes for human RING1B (also known as RNF2), BMI1, UbcH5C (UBE2D3) and UBA1 were amplified from HeLa complementary DNA. Gene fragments of BRCA1 and BARD1 containing the RING domains were amplified from HeLa and U2OS cDNA, respectively. The gene for ubiquitin was synthesized by Invitrogen. UbcH5c(2-147), Uba1(2-1058) and ubiquitin were each cloned into pST50Tr vectors with an N-terminal tandem Strep peptide (STR)-decahistidine (His 10 ) affinity tag. STR-His 10 -Ring1B(2-116)-Bmi1(2-109) and STR-His10-BRCA1(2-103)-BARD1 were each cloned into pST44 vectors for polycistronic co-expression 37 . A similar pST44 vector was created to co-express Bmi1(2-109) with Ring1B fused in frame to UbcH5c(2-147) through a linker encoding the protein sequence, GSGSRS. Point mutants were generated by site-directed mutagenesis. The fused human PRC1 ubiquitylation module containing Bmi1(2-109) and STR-His 10 -Ring1B(2-116)-GSGSRS-UbcH5c(2-157) was expressed in Rosetta(DE3)pLysS Escherichia coli at 18 uC. The complex was enriched by metal-affinity chromatography with Talon resin (Clonetech), the affinity tag removed with tobacco etch virus (TEV) protease and the complex further purified by SourceS cation-exchange chromatography (GE Healthcare). The Ring1B(2-116)-Bmi1(2-109) complex and UbcH5c(2-147) single protein were expressed and purified similarly. STR-His 10 -Uba1(2-1058) and STR-His 10 -ubiquitin(1-76) were expressed in CodonPlus(DE3) and BL21(DE3)pLysS E. coli at 18 uC and 37 uC, respectively. Uba1 was purified by metal-affinity chromatography as above, followed by SourceQ anion-exchange chromatography (GE Healthcare) without cleavage of the affinity tag. Ubiquitin was purified similarly with the affinity tag intact using SourceS cation-exchange chromatography. The STR-His 10 -BRCA1(2-103)-BARD1 complex was expressed in Rosetta(DE3)pLysS E. coli at 18 uC and purified by metal-affinity chromatography, TEV cleavage, and SourceQ anion-exchange chromatography. All mutants were expressed and purified identically to their wild-type versions including ion-exchange chromatography. Histone mutants were generated by site-directed mutagenesis. Recombinant Xenopus histones were expressed, purified and reconstituted with the 147-or 185-bp Widom 601 sequence 38 essentially as described previously 39 including anion-exchange purification of NCPs. Fluorescent labelling of histones was performed as described 31 . Characterization of proteins and protein complexes. All proteins and complexes were evaluated by dynamic light scattering using a Protein Solutions DynaPro instrument. Scattering was analysed using the Dynamics v6 software package. All E2 and E3 mutants showed equivalent monodispersity to their wild-type controls (polydispersity ,20%). Owing to paradoxical binding and activity results, the secondary structure of Bmi(Glu33Ala) mutant E3 heterodimer and fused E2-E3 complexes were further analysed and compared to wild-type controls using a Jasco J-1500 Circular Dichroism Spectrometer. Spectra were obtained at 0.1 mg ml 21 protein concentration in 2 mM Tris-Cl, pH 7.6, containing 150 mM NaF. Data were analysed using CDPro. Complex reconstitution and crystallization. The PRC1 ubiquitylation module was reconstituted with NCPs prepared with 147-bp 601 DNA at a 2.8-3.0:1 module: nucleosome ratio in 20 mM Tris-Cl, pH 7.6, 75 mM NaCl, 10 mM ZnSO 4 , 1 mM dithiothreitol (DTT). The complex was purified by Superdex 200 size exclusion chromatography (GE Healthcare) in reconstitution buffer supplemented with 0.2 mM phenylmethylsulphonyl fluoride (PMSF). Pooled fractions were concentrated to ,10 mg ml 21 by VS500 centrifuge ultrafiltration (Vivascience). Crystallization was performed in modified microbatch 40 by combining 1 ml of the concentrated complex with 1 ml 25 mM HEPES, pH 7.5 (Hampton), 80 mM NH 4 NO 3 (Hampton), and 3% PEG 2000-MME (Fluka) at 21 uC overlayed by 70 ml Al's oil (1:1 mixture of silicon oil (Clearco) and mineral oil (Fisher)). Crystals were collected after 12-60 days. Cryoprotection and dehydration was performed by soaking in 25 mM HEPES, pH 7.5, 120 mM NH 4 NO 3 , 2.5% ethanol, 0.5 mM DTT, and 5% PEG 2000-MME with increasing amounts of PEG 550-MME (Fluka, 0-28% in 4% increments, every 10-15 min) at room temperature before flash cooling in liquid nitrogen. Data collection, data processing, model building and refinement. Diffraction data were collected at Advanced Photon Source's NE-CAT beamline 24-ID-E (0.9792 Å ; 100 K). Data were processed using XDS 41 and Scala 42 . The structure was solved by molecular replacement with Phaser 43 and polyalanine versions of the PRC1 ubiquitylation module 22 (PDB code 3RPG) and the NCP with 145-bp Widom 601 DNA 25 (PDB code 3LZ0) as rigid body search models (Phaser final log likelihood gain 3,700). Crystallographic refinement was performed with iterative automatic refinement using REFMAC5 44, 45 , PHENIX 46 , and CNS 47 together with manual model building in COOT 48 . The structure was refined to 3.3 Å resolution with R work /R free 19.7%/24.5%. The asymmetric unit contains one copy of the 2:1 PRC1 ubiquitylation module-NCP complex in C222 1 space group. The final model includes Bmi1 residues 3-107 for chain K, residues 6-102 for chain M; Ring1B residues 15-116 for chain L, 16-116 for chain N; UbcH5c residues 2-147 for chain L, 2-147 for chain N (residues for UbcH5c are offset by 200 in the PDB file (that is, 202-347), linker between Ring1B and UbcH5c in final model residues 117-122 for chains L and N); H3 residues 37-134 for chain A, residues 38-134 for chain E; H4 residues 17-102 for chain B, residues 21-102 for chain F; H2A residues 16-119 for chain C, residues 12-118 for chain G; H2B residues 31-125 for chain D, residues 31-125 for chain H; 601 DNA residues 271 to 172 for chain I, residues 272 to 172 for chain J. The histone tails are typically not observed in NCP structures. Above average B-factors are typical for structures containing the NCP especially at resolutions greater than 3 Å 30,49-51 . Ramachandran statistics were analysed with PROCHECK 52 (88.4% of residues in most favoured regions, 11.5% in additional allowed regions, 0.1% in generously allowed regions, 0.1% in disallowed regions -disallowed residue corresponds to Ser 122 to in L chain contained in fusion between Ring1B and UbcH5c). Simulated annealing omits maps cumulatively covering the entire structure were generated with CNS. All molecular graphics were prepared with PyMOL 53 . Buried surface areas and r.m.s.d. values for structure alignments were calculated using PyMOL. Ubiquitylation assays. Ubiquitylation assays were performed by mixing 2 mM NCP, 5 mM STR-His 10 -ubiquitin, 30 nM STR-His 10 -Uba1 (E1), 0.375 mM UbcH5c (E2) and 0.375 mM Ring1B(2-116)-Bmi1(2-109) or BRCA1(2-103)-BARD1(27-130) (E3) in 50 mM HEPES, pH 7.5, 75 mM NaCl, 1 mM DTT, 10 mM ZnSO 4 , 2 mM MgCl 2 , 3 mM ATP. For histone mutants assays, non-fluorescent nucleosomes with an STR-His 6 -tagged H2B were used. For PRC1 ubiquitylation module mutants, wild-type recombinant nucleosomes were doped with 5% nucleosomes containing the H2A(Thr10Cys) mutant labelled with Oregon Green 488 maleimide. Assay samples ranging from 20 to 80 ml were placed in a water bath for 60 min at 30 uC after which assays were quenched with an equivalent volume of 23 SDS-PAGE gel loading dye and boiled for 5 min. Assay samples were separated by SDS-PAGE using 18% gels, scanned with a Typhoon 9410 imager (GE Healthcare; 488 nm excitation; 526 nm emission; PMT 500) and stained with Coomassie brilliant blue. Quantification of assays was performed using Image Quant software by drawing boxes around each band. Each quantified band was background subtracted using an identically sized box in a region of the same lane without signal. As only unmodified H2A, H2Aub1, H2Aub2 and H2Aub3 were observed, the sum of these background-subtracted bands was considered to be the total H2A for each lane. In this manner, fraction of total H2A was calculated for each band. These fractional values could be compared across gels reproducibly (Extended Data Fig. 6 ). Three technical replicates were performed for each mutant with all mutants of a given type (that is, all Ring1B mutants) executed simultaneously with both positive and negative controls. In most cases, three gels were run each containing one of the three replicates of each of the mutants in a given data set. n 5 3 was found to be sufficient for reproducible data (Extended Data Fig. 6 ) with low standard deviations. Assays for E1-mediated transfer of ubiquitin to UbcH5c Cys85Lys mutants were performed as previously described 16 . In brief, 100 mM STR-His 10 -ubiquitin, 1 mM STR-His 10 -Uba1 (E1), 80 mM UbcH5c or fused PRC1 ubiquitylation module with the Cys85Lys mutant were combined in 50 mM Tris-Cl, pH 10, 150 mM NaCl, 8 mM TCEP, 5 mM MgCl2 and incubated at 35 uC for 24 h. Assay samples were separated by SDS-PAGE and stained as described above. UbcH5c aminolysis assays. To assess intrinsic function of previously uncharacterized UbcH5c mutants, lysine reactivity aminolysis assays were performed basically as previously described 33 . In brief, 20 mM UbcH5c (wild-type or mutant) was combined with 20 mM STR-His 10 -ubiquitin and 0.5 mM STR-His 10 -Uba1 (E1) in 80 ml of 25 mM sodium phosphate, pH 7.0, 150 mM NaCl, 10 mM MgCl 2 and 10 mM ATP. Following a 20-min incubation at 37 uC, lysine was added to a final concentration of 50 mM. Aminolysis time points were taken at 0, 10 and 30 min and analysed by SDS-PAGE. Reduction of the no-lysine control was performed with 100 mM DTT. Nucleosome binding assays. Nucleosome binding assays were performed with nucleosomes reconstituted with a H2B(Ser112Cys) mutant labelled with Oregon Green 488 maleimide (Life Technologies) with approximately ,50% efficiency and 147-or 185-bp 601 DNA. Fluorescence quenching assays were performed essentially as previously described 31 . In brief, chromatin binding proteins (wild-type or mutant-fused PRC1 ubiquitylation module or Ring1B-Bmi1 and/or UbcH5c) were diluted in 20 mM Tris-Cl, pH 7.6, 100 mM NaCl, 5 mM DTT, 5% glycerol, 0.01% NP-40, 0.01% CHAPS, 0.1 mg ml 21 BSA to concentrations of 50, 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, 0.062, 0.031 and 0.016 mM. The labelled nucleosome was diluted to 2 nM in identical buffer containing 50 mM NaCl. Twenty microlitres of NCP was added to 20 ml of each protein/complex dilution in triplicate in a passivated 384well plate (Greiner). Following centrifugation, mixing and 10-20-min incubation, plates were scanned with a Typhoon 9410 imager (488 nm excitation; 526 nm emission; PMT 600). Fluorescence was quantitated with ImageQuant software and data was analysed with ProFit (QuantumSoft). For E2 titration experiments, UbcH5c was added at twice the indicated concentration to each of the Ring1B-Bmi1 dilutions, giving the final indicated concentration following 1:1 mixing with the fluorescent NCP. n 5 3 was found to be sufficient for reproducible data (Extended ARTICLE RESEARCH
